Work

Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease

Year: 2023

Type: article

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(23)00247-8

Authors: Kai Schlepckow, Estrella Morenas-Rodríguez, Soyon Hong, Christian Haass

Institutions: German Center for Neurodegenerative Diseases, Research Institute Hospital 12 de Octubre, Hospital Universitario 12 De Octubre, UK Dementia Research Institute, UCL Queen Square Institute of Neurology, University College London, Munich Cluster for Systems Neurology, Ludwig-Maximilians-Universität München

Language: English

Topic: Neuroinflammation and Neurodegeneration Mechanisms

Subfield: Neurology

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Alzheimer's Society, Deutsche Forschungsgemeinschaft, Alzheimer’s Research UK, UK Dementia Research Institute, Medical Research Council, Instituto de Salud Carlos III

Awards: G1054881166, G1183059914, G1884696846, EXC 2145: Munich Cluster for Systems Neurology (SyNergy), Factores relacionados con la activación microglial dependiente de TREM2 en la demencia con cuerpos de Lewy, influencia sobre su evolución y aplicaciones clínicas.

OpenAlex ID: W4387761639

FWCI: 9.43

Cites: 100

Cited by: 115

Related to: 10